Metformin Hydrochloride

This article explores various clinical trials involving Metformin Hydrochloride, a widely used medication for treating type 2 diabetes. The trials focus on different aspects of the drug, including new formulations, patient adherence, and pharmacokinetic properties. These studies aim to improve the effectiveness and patient experience of Metformin treatment.

Table of Contents

What is Metformin?

Metformin Hydrochloride, commonly known as Metformin, is a widely used medication primarily prescribed for the treatment of type 2 diabetes mellitus. It’s also known by the brand name Glucophage[1]. Metformin belongs to a class of drugs called biguanides, which work to lower blood sugar levels in the body.

Conditions Treated with Metformin

While Metformin is primarily used for treating type 2 diabetes, research shows it may be beneficial for other conditions as well:

  • Type 2 Diabetes: This is the primary use of Metformin. It helps control blood sugar levels in people with type 2 diabetes[1].
  • Metabolic Syndrome: Metformin is being studied for its potential to prevent age-related chronic diseases in people with metabolic syndrome[1].
  • Polycystic Ovary Syndrome (PCOS): Metformin may help regulate menstrual irregularities and reduce excessive male hormones (hyperandrogenism) in women with PCOS[2].
  • Cancer: Some studies are exploring Metformin’s potential anti-cancer properties, particularly in lung cancer and neuroendocrine tumors[3][4].
  • Chronic Kidney Disease: Research is being conducted on the use of Metformin in patients with various stages of chronic kidney disease[5].

How Metformin Works

Metformin works in several ways to help control blood sugar levels:

  • It reduces the amount of glucose produced by the liver.
  • It increases the sensitivity of body tissues to insulin, allowing the body to use glucose more effectively.
  • It decreases the absorption of glucose from the intestines.

Additionally, Metformin may have other effects in the body. For example, it may help reduce inflammation and improve insulin sensitivity, which could explain its potential benefits in conditions beyond diabetes[3].

Forms and Dosages

Metformin is available in different forms and dosages:

  • Immediate-release tablets: These are typically taken 2-3 times a day with meals. Common dosages include 500 mg, 850 mg, and 1000 mg[6].
  • Extended-release tablets (XR): These are usually taken once daily with the evening meal. They come in 500 mg, 750 mg, and 1000 mg strengths[5].

The dosage is usually started low and gradually increased to minimize side effects. Your doctor will determine the right dosage for you based on your condition and response to the medication.

Side Effects and Safety

Like all medications, Metformin can cause side effects. Common side effects include:

  • Nausea
  • Diarrhea
  • Stomach upset
  • Loss of appetite

These side effects often improve over time. Taking Metformin with food can help reduce these gastrointestinal effects.

A rare but serious side effect of Metformin is lactic acidosis, a condition where lactic acid builds up in the blood. This is more likely to occur in people with kidney problems, liver disease, or conditions that cause low oxygen levels[5].

It’s important to follow your doctor’s instructions carefully when taking Metformin and to report any unusual symptoms promptly.

Ongoing Research and Potential New Uses

Researchers are continually studying Metformin to understand its full potential. Some areas of ongoing research include:

  • Cancer treatment: Studies are investigating whether Metformin can help improve outcomes in certain types of cancer, such as lung cancer and neuroendocrine tumors[3][4].
  • Anti-aging effects: Some research suggests Metformin may have anti-aging properties and could potentially prevent age-related chronic diseases[1].
  • Skin conditions: There’s ongoing research into the potential use of Metformin for treating melasma, a skin condition causing dark patches on the face[7].

While these potential new uses are exciting, it’s important to remember that more research is needed before Metformin can be recommended for these conditions. Always consult with your healthcare provider before using Metformin for any purpose other than what it was prescribed for.

Study Focus Key Findings/Objectives Formulations Studied
Treatment Adherence Compared compliance between Glucophage sachets and tablets in type 2 diabetes patients Glucophage sachets, Glucophage tablets
Bioequivalence Assessed bioequivalence between Glucophage XR tablets manufactured in different locations Glucophage XR 750mg tablets
Pharmacokinetics in Twins Compared metformin pharmacokinetics in monozygotic and dizygotic twins to understand genetic influences Metformin HCl 850mg tablets
New Formulation Bioequivalence Assessed bioequivalence of a new reduced mass Glucophage XR tablet compared to the standard formulation Glucophage XR 500mg, Glucophage XR RM 500mg
Combination Therapy Evaluated pharmacokinetics of metformin in combination with another diabetes medication CKD-395 (combination of metformin and another drug)

Ongoing Clinical Trials on Metformin Hydrochloride

  • A Study of Metformin for Slowing Down Aging Effects in Patients with Chronic Obstructive Pulmonary Disease

    Recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study of metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome

    Recruiting

    1 1 1 1
    Germany
  • Study on Acupuncture and Metformin for Improving Insulin Sensitivity in Women with Polycystic Ovary Syndrome

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study on Metformin for Preventing Leukemia in Patients with Clonal Cytopenia and Low-Risk Myelodysplastic Syndromes

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study of Pioglitazone and Metformin combination treatment for patients with Metabolic Associated Fatty Liver Disease and prediabetes

    Recruiting

    1 1 1 1
    Investigated diseases:
    Spain
  • Study on the Effect of Metformin on Endometrial Function in Women with Unexplained Infertility

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on the Effect of Metformin on Fertility in Women with Thyroid Cancer Treated with Radioactive Iodine

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on Metformin for Patients with Esophageal Cancer to Enhance Chemoradiotherapy Response

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on How Metformin Affects Arterial Calcification in Patients with Type 1 Diabetes Without Chronic Kidney Disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Metformin to Extend Pregnancy Duration in Women with Preterm Preeclampsia

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Metformin Hydrochloride: A medication used to treat type 2 diabetes by helping to control blood sugar levels.
  • Bioequivalence: The property of different formulations of a drug having the same biological effect and safety profile when administered to patients.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Extended Release (XR): A formulation of a medication designed to release the active ingredient slowly over time, allowing for less frequent dosing.
  • Glucophage: A brand name for Metformin Hydrochloride.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, used in pharmacokinetic studies.
  • Cmax: The maximum concentration of a drug in the blood after administration.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood.
  • Half-life: The time it takes for the concentration of a drug in the body to decrease by half.
  • Fasting state: A condition where a person has not eaten for a certain period, often used in drug studies to control for food effects.
  • Fed state: A condition where a person has recently eaten, used in drug studies to understand how food affects drug absorption.
  • Treatment-Emergent Adverse Events (TEAEs): Side effects or undesirable experiences that occur after starting a new treatment in a clinical trial.

References

  1. https://clinicaltrials.gov/study/NCT02960711
  2. https://clinicaltrials.gov/study/NCT03757923
  3. https://clinicaltrials.gov/study/NCT01997775
  4. https://clinicaltrials.gov/study/NCT02279758
  5. https://clinicaltrials.gov/study/NCT02895750
  6. https://clinicaltrials.gov/study/NCT01710527
  7. https://clinicaltrials.gov/study/NCT03475524